FDA Clears CEL-SCI’s Multikine Study for Head and Neck Cancer CEL-SCI Corporation (CVM), a leader in immunotherapy, announced FDA approval of its patient… BioTech Health XNovember 8, 2024 0 Shares 0 0 0 0 0 0 0
Aethlon (AEMD) Reports Q1 2024 Results and Advances Cancer and Virus Treatment Trials BioTech Health XNovember 7, 2024
Taysha Gene (TSHA) Reports Strong Q2 2024 Results and Advances TSHA-102 Trials BioTech Health XNovember 5, 2024
CEL-SCI’s Multikine Immunotherapy Boosts 5-Year Survival Rate in Head and Neck Cancer BioTech Health XSeptember 16, 2024
Biotech NewsFDA Clears CEL-SCI’s Multikine Study for Head and Neck Cancer BioTech Health XNovember 8, 2024
Biotech NewsAethlon (AEMD) Reports Q1 2024 Results and Advances Cancer and Virus Treatment Trials BioTech Health XNovember 7, 2024
Biotech NewsTreace Medical (TMCI) Reports 11% Revenue Growth in Q3 2024 BioTech Health XNovember 6, 2024
Biotech NewsTaysha Gene (TSHA) Reports Strong Q2 2024 Results and Advances TSHA-102 Trials BioTech Health XNovember 5, 2024
Biotech NewsCEL-SCI’s Multikine Immunotherapy Boosts 5-Year Survival Rate in Head and Neck Cancer BioTech Health XSeptember 16, 2024
FDA Clears CEL-SCI’s Multikine Study for Head and Neck Cancer BioTech Health XNovember 8, 2024 CEL-SCI Corporation (CVM), a leader in immunotherapy, announced FDA approval of its patient selection strategy for the upcoming… Read More 0 Shares 0 0 0 0 0 0 0
Aethlon (AEMD) Reports Q1 2024 Results and Advances Cancer and Virus Treatment Trials BioTech Health XNovember 7, 2024 Aethlon Medical, Inc. (AEMD), a pioneering company in cancer and infectious disease therapies, has reported its fiscal Q1… Read More 0 Shares 0 0 0 0 0 0 0
Treace Medical (TMCI) Reports 11% Revenue Growth in Q3 2024 BioTech Health XNovember 6, 2024 Treace Medical Concepts, Inc. (TMCI), a leading innovator in the medical technology space focused on bunion treatment, announced… Read More 0 Shares 0 0 0 0 0 0 0
Taysha Gene (TSHA) Reports Strong Q2 2024 Results and Advances TSHA-102 Trials BioTech Health XNovember 5, 2024 Taysha Gene Therapies, Inc. (TSHA), a leader in developing AAV-based gene therapies for severe central nervous system diseases,… Read More 0 Shares 0 0 0 0 0 0 0
CEL-SCI’s Multikine Immunotherapy Boosts 5-Year Survival Rate in Head and Neck Cancer BioTech Health XSeptember 16, 2024 CEL-SCI Corporation (NYSE American: CVM) has announced new breakthrough data from its Phase 3 trial of Multikine®, an… Read More 0 Shares 0 0 0 0 0 0 0
Novartis Pioneers RNA Therapeutics with Borealis Biosciences for Kidney Diseases BioTech Health XAugust 22, 2024 Introduction In a groundbreaking move for the biotech industry, Novartis has partnered with Versant Ventures to establish Borealis… Read More 0 Shares 0 0 0 0 0 0 0
Genentech’s Strategic Pivot: The Closure of Its Cancer Immunology Unit BioTech Health XAugust 22, 2024 Introduction In a significant and somewhat unexpected move within the biotech industry, Genentech, a subsidiary of Roche, has… Read More 0 Shares 0 0 0 0 0 0 0
Breakthrough in Alzheimer’s Treatment: Biogen and Eisai’s Leqembi Wins UK Approval BioTech Health XAugust 22, 2024 Introduction The landscape of Alzheimer’s disease treatment has undergone a monumental shift with the UK’s Medicines and Healthcare… Read More 0 Shares 0 0 0 0 0 0 0
Vera Therapeutics’ Atacicept Shows Promising Results in Phase 2b ORIGIN Trial for IgA Nephropathy BioTech Health XMay 25, 2024 Vera Therapeutics has announced positive results from their Phase 2b ORIGIN clinical trial for atacicept, a novel investigational… Read More 0 Shares 0 0 0 0 0 0 0
Ozempic Shows Lower Risk of Kidney and Heart Complications in Diabetic Patients BioTech Health XMay 24, 2024 In a groundbreaking development, Novo Nordisk’s Ozempic (semaglutide) has demonstrated significant benefits in reducing the risk of kidney… Read More 0 Shares 0 0 0 0 0 0 0
Eli Lilly Announces Historic $5.3 Billion Investment to Expand Indiana Manufacturing for Diabetes and Weight Loss Drugs BioTech Health XMay 24, 2024 Expansion to Create 900 Permanent Jobs and Meet Rising Demand for Mounjaro and Zepbound Eli Lilly and Company… Read More 0 Shares 0 0 0 0 0 0 0
Guardant Health’s Shield Blood Test for Colorectal Cancer Receives FDA Advisory Panel Endorsement BioTech Health XMay 24, 2024 Guardant Health, a prominent player in precision oncology, has taken a significant step forward with its Shield blood… Read More 0 Shares 0 0 0 0 0 0 0
Coherus Presents Promising Phase I Results for Anti-CCR8 Antibody CHS-114 at ASCO 2024 BioTech Health XMay 23, 2024 Coherus BioSciences has announced preliminary results from its Phase I dose-escalation study of CHS-114, an anti-CCR8 antibody, at… Read More 0 Shares 0 0 0 0 0 0 0
Myriad Genetics Unveils Groundbreaking Cancer Care Innovations at ASCO 2024 BioTech Health XMay 23, 2024 Myriad Genetics has once again solidified its position at the forefront of precision medicine and genetic testing with… Read More 0 Shares 0 0 0 0 0 0 0
Biogen Expands Immunology Portfolio with Strategic Acquisition BioTech Health XMay 23, 2024 Biogen Inc. has announced the acquisition of Human Immunology Biosciences (HI-Bio) for an upfront payment of $1.15 billion,… Read More 0 Shares 0 0 0 0 0 0 0
Takeda Inks Licensing Deal with Degron Therapeutics for Molecular Glue Degraders BioTech Health XMay 23, 2024 Takeda Pharmaceuticals has announced an exclusive licensing agreement with Degron Therapeutics, a Chinese biotech company, to develop novel… Read More 0 Shares 0 0 0 0 0 0 0
FDA Approves Biosimilars Yesafili and Opuviz, Opening New Avenues for Affordable Eye Treatments BioTech Health XMay 21, 2024 The FDA has recently approved two new biosimilars, Yesafili (aflibercept-jbvf) by Biocon Biologics and Opuviz (aflibercept-yszy) by Samsung… Read More 0 Shares 0 0 0 0 0 0 0
Oak Hill Bio and Chiesi Resume Phase 2b Clinical Study for OHB-607 to Treat Bronchopulmonary Dysplasia BioTech Health XMay 17, 2024 Oak Hill Bio and Chiesi Group have announced the enrollment of the first patient in a resumed Phase… Read More 0 Shares 0 0 0 0 0 0 0